Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 1/20 | 0.60 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.53 |
| ▸ | CTSK | P43235 | 4/20 | 0.47 |
| ▸ | CTSL | P07711 | 3/20 | 0.47 |
| ▸ | CTSS | P25774 | 3/20 | 0.47 |
| ▸ | CTSB | P07858 | 2/20 | 0.47 |
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | CA9 | Q16790 | 2/20 | 0.47 |
| ▸ | CASP3 | P42574 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12208730 | 0.90 | SYK (0.52) | SYKCTRB1CTSKCTSLCTSS | |
| SCHEMBL19050929 | 0.90 | SYK (0.52) | SYKCTRB1CTSKCTSLCTSS | |
| SCHEMBL20640409 | 0.90 | SYK (0.52) | SYKCTRB1CTSKCTSLCTSS | |
| SCHEMBL7342332 | 0.90 | CTRB1 (0.64) | SYKCTRB1CTSKCTSLCTSS | |
| SCHEMBL7367948 | 0.90 | CTRB1 (0.64) | SYKCTRB1CTSKCTSLCTSS | |
| SCHEMBL7367945 | 0.90 | CTRB1 (0.64) | SYKCTRB1CTSKCTSLCTSS | |
| SCHEMBL4343315 | 0.89 | CTRB1 (0.52) | SYKCTRB1ELANEATMCA12 | |
| SCHEMBL4343313 | 0.89 | CTRB1 (0.52) | SYKCTRB1ELANEATMCA12 | |
| SCHEMBL14842341 | 0.89 | CTRB1 (0.52) | SYKCTRB1CTSKELANECYP1A2 | |
| SCHEMBL14842340 | 0.89 | CTRB1 (0.52) | SYKCTRB1CTSKELANECYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3395796-B1 | A CRYSTALLINE TRIHYDRATE FORM OF (3S,3S') 4,4'-DISULFANEDIYLBIS (3-AMINOBUTANE 1-SULFONIC ACID) | QUANTUM GENOMICS (FR) | 2021-11-24 | — | — | EP | disclosed |
| EP-3395796-A1 | A CRYSTALLINE TRIHYDRATE FORM OF (3S,3S ) 4,4 -DISULFANEDIYLBIS (3-AMINOBUTANE 1-SULFONIC ACID) | Quantum Genomics (FR) | 2018-10-31 | — | — | EP | disclosed |
| US-9340497-B2 | Method for the preparation of (3S,3S′) 4,4′-disulfanediylbis (3-aminobutane 1-sulfonic acid) | QUANTUM GENOMICS (FR) | 2016-05-17 | — | — | US | disclosed |
| US-20160046571-A1 | METHOD FOR THE PREPARATION OF (3S,3S') 4,4'-DISULFANEDIYLBIS (3-AMINOBUTANE 1-SULFONIC ACID) | QUANTUM GENOMICS (FR) | 2016-02-18 | — | — | US | disclosed |
| US-9187418-B2 | Method for the preparation of (3S, 3S′) 4,4′-disulfanediylbis (3-aminobutane 1-sulfonic acid) | QUANTUM GENOMICS (FR) | 2015-11-17 | — | — | US | disclosed |
| US-20130231500-A1 | METHOD FOR THE PREPARATION OF (3S, 3S') 4,4'-DISULFANEDIYLBIS (3-AMINOBUTANE 1-SULFONIC ACID) | QUANTUM GEOMICS (FR) | 2013-09-05 | — | — | US | disclosed |
| EP-2625163-A1 | METHOD FOR THE PREPARATION OF (3S,3S') 4,4'-DISULFANEDIYLBIS (3-AMINOBUTANE 1-SULFONIC ACID) | Quantum Genomics (FR) | 2013-08-14 | — | — | EP | disclosed |
| WO-2012045849-A1 | METHOD FOR THE PREPARATION OF (3S,3S') 4,4'-DISULFANEDIYLBIS (3-AMINOBUTANE 1-SULFONIC ACID) | QUANTUM GENOMICS (FR) | 2012-04-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160046571-A1 | METHOD FOR THE PREPARATION OF (3S,3S') 4,4'-DISULFANEDIYLBIS (3-AMINOBUTANE 1-SULFONIC ACID) | STS, TST, CYP2S1 | SYK 2623/4885CTRB1 966/4885CTSK 3916/4885 |
| US-20130231500-A1 | METHOD FOR THE PREPARATION OF (3S, 3S') 4,4'-DISULFANEDIYLBIS (3-AMINOBUTANE 1-SULFONIC ACID) | STS, TST, CYP2S1 | SYK 2623/4885CTRB1 966/4885CTSK 3916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.